DNA(RNA) Synthesis

DNA(RNA) Synthesis

RNA synthesis, which is also called DNA transcription, is a highly selective process.Beyond RNA synthesis, RNA polymerase II transcription plays a more active role in the maturation, monitoring, and export of mRNA to the cytoplasm.

In order to fully repair the DNA after a single-strand break, DNA ligase constructs the final phosphodiester bond using the complementary strand of the double helix as a template.Substrates with RNA strands or mismatched base pairs near the ends of the nicked DNA are discriminated against by DNA ligases. Bleomycin (BLM) is a S-independent radiomimetic agent that damages DNA by creating free radicals that attack the C-4′ position in the deoxyribose backbone. This causes the ribose ring to open and strand breaks to occur.

M-MuLV Reverse Transcriptase (RNase H) and random hexamer primers are used to create first strand cDNA. The next step involves the use of DNA Polymerase I and RNase H to create second strand cDNA. Exonuclease/polymerase activity transforms the remaining overhangs into blunt ends. DNA fragments' 3′ ends are adenylated before being ligated with a NEBNext Adaptor with a hairpin loop structure to get the samples ready for hybridization. The two pathways that BET bromodomain inhibition most commonly affects are cell cycle and DNA replication. The translation of mRNA into proteins is inhibited by cycloheximide.

DNA(RNA) Synthesis related products

Structure Cat No. Product Name CAS No. Product Description
V55198 N4-Bz-5'-O-DMTr-3'-deoxy-3'-fluoro-beta-D-xylofuranosyl cytidine-2'-CED-phosphoramidite 1555759-30-2 N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-3'-deoxy-3'-fluoro-beta-D-xylofuranosyl cytidine-2'-CED-phosphoramidite is a phosphoramidite monomer, Can be used for solid-phase synthesis of oligonucleotides.
V55206 N6-Benzoyl-2'-deoxy-5'-O-DMT-a-adenosine 3'-CE phosphoramidite 152695-84-6 N6-Benzoyl-2'-deoxy-5'-O-DMT-a-adenosine 3'-CE phosphoramidite is a phosphoramidite monomer that may be utilized in the preparation /synthesis of oligonucleotides.
V55118 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (m7GpppA) 62828-63-1 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (m7GpppA) is a dinucleotide cap analog for in vitro RNA transcription.
V53208 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine diammonium (m7GpppA diammonium) 75252-10-7 N7-Methyl-guanosine-5'-triphosphate-5'-adenosine (m7GpppA) diammonium is a dinucleotide cap analog for in vitro RNA transcription.
V41133 NCGC00029283 714240-31-0 NCGC00029283 is a novel inhibitor of Werner syndrome helicase-nuclease (WRN) with IC50s of 2.3 μM, 12.5 μM, and 3.4 μM for WRN, BLM, and FANCJ helicases, respectively.
V1471 Nedaplatin (NSC 375101D) 95734-82-0 Nedaplatin (formerly NSC-375101D; NSC 37510D;NSC-375101 D;NSC 375101-D; trade name Aqupla) is a cisplatin analog and DNA damaging agent approved as an anticancer medication.
V1455 Nelarabine (Arranon; 506U78) 121032-29-9 Nelarabine (formerly 506 U78; GW-506U78; NS-686673; 506U78; GW506U78; Atriance; Arranon; Nelzarabine) is a cytotoxic/chemotherapeutic medication approved for use in the treatment of hematological malignancies (T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma).
V14759 Neobavaisoflavone 41060-15-5 Neobavaisoflavone is a naturally occurring flavonoid isolated from the seeds of Psoralea corylifolia with anti-inflammatory, anti-cancer and anti-oxidation activities.
V5089 Nimustine HCl (ACNU) 55661-38-6 Nimustine hydrochloride (also known as ACNU), an approved chemotherapeutic drug, is a potent DNA cross-linking and DNA alkylating agent for cancer treatment, it induces DNA replication blocking lesions and DNA double-strand breaks and inhibitsDNA synthesis, commonly used in chemotherapy for especially glioblastomas / malignant brain tumors.
V41105 NITD-2 1197896-79-9 NITD-2 is an inhibitor of the dengue virus (DENV) polymerase that prevents the DENV RdRp protein from causing RNA elongation.
V31979 NKP-1339 (IT-139; KP-1339) 197723-00-5 NKP-1339(IT139; KP1339) is the first-in-class and potent ruthenium-based anticancer drug under clinical investigation for treating solid cancer with limited side effects.
V41094 NSC 617145 203115-63-3 NSC 617145 is a selective inhibitor of Werner syndrome helicase (WRN) helicase with an IC50 value of 230 nM.
V51607 NSC-80467 101982-51-8 NSC 80467 is a DNA damaging agent and selectively inhibits survivin.
V53143 NSC639828 134742-26-0 NSC639828 is a selective inhibitor of DNA polymerase α with an IC50 of 70 μM. NSC639828 exhibits strong antitumor properties.
V55131 Nuclease S1 37288-25-8 Nuclease S1 is an endonuclease that specifically breaks down RNA and single-stranded DNA (ssDNA).
V0057 Oxaliplatin (Eloxatin; L-OHP; JM-83; RP-54780; SR-96669) 61825-94-3 Oxaliplatin (Eloxatin; L-OHP; JM83; RP54780; SR96669),an anticancer drug used for treating colorectal cancer,is an organoplatinum complex (1,2-diaminocyclohexane (DACH) and with an oxalate ligand), acnting by inhibiting DNA synthesis by forming DNA adducts in RT4, TCCSUP, A2780, HT-29, U-373MG, U-87MG, SK-MEL-2, and HT-144 cells.
V56311 Oxolinic acid-d5 (oxolinic acid d5) 1189890-98-9 Oxolinic acid-d5 is the deuterated product of Oxolinic acid.
V0846 Pemetrexed disodium 150399-23-8 Pemetrexed disodium (formerly HSDB-7316; LY-231514; Alimta), the disodium salt ofPemetrexed, is a marketed anticancer drug of the antifolate and antimetabolite class.
V2481 pentixather Desription: Pentixather, structurally similar to PentixaFor, is an iodinated form of PentixaFor which is a ligand/intermediate used for the preparation of gallium Ga 68-pentixafor.
V19201 PFM01 1558598-41-6 PFM01 is a nuclease-specific MRE11 inhibitor.
Contact Us Back to top